Nasivin Classic (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nasivin Classic, is a alpha‑adrenergic agonist presented as a nasal spray for topical nasal use. It relieves nasal congestion in adults and children experiencing colds, allergies, or sinus pressure.

GNH USA supplies Nasivin Classic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline Hydrochloride acts as a topical nasal decongestant to reduce swelling of the nasal mucosa. - Common cold: alleviates nasal blockage and improves airflow. - Allergic rhinitis: reduces congestion caused by allergic inflammation. - Acute sinusitis: helps clear nasal passages and eases pressure.

Adverse reactions may occur with nasal administration of oxymetazoline.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing or mild itching. - Headache. - Transient taste disturbance.

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa) after prolonged use. - Elevated blood pressure or hypertension. - Tachycardia or irregular heart rhythm. - Severe allergic reaction (anaphylaxis). - Persistent nasal ulceration.

Use Nasivin Classic with awareness of specific safety considerations. - Do not exceed recommended duration: limit use to no more than three consecutive days. - Avoid use in children under six years: consult a pediatrician before administration. - Use with caution in hypertension: monitor blood pressure during treatment. - Avoid concurrent use with monoamine oxidase inhibitors (MAOIs): discuss with a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Oxymetazoline may interact with other sympathomimetic agents and cardiovascular drugs.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other nasal decongestants: additive vasoconstriction may cause severe hypertension. - Systemic sympathomimetics (e.g., epinephrine): may lead to excessive cardiovascular stimulation.

Moderate Interactions (Monitor Closely):\n- Antihypertensive medications: possible reduction in blood‑pressure‑lowering effect. - Beta‑blockers: may blunt compensatory heart‑rate response. - Tricyclic antidepressants: increased likelihood of cardiovascular side effects.